the potential of targeting non-malignant cells in the cll microenvironment
Published 8 hours ago • 14 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:41
metabolism in cll cells: its dynamic nature and influence on the microenvironment
-
1:23
mechanical forces in the cll microenvironment and the importance of modeling them in vitro
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:17
the evolution of frontline treatment for cll: from chemoimmunotherapy to targeted agents
-
0:57
the potential of the tsafinder tool in hematological oncology
-
9:53
flow cytometry - 4 | cd markers| t cell acute lymphoblastic leukemia & nk cells -- 10 minutes !!!!
-
39:06
expanding the benefits of immuno-oncology through novel rational targets and combinations
-
58:27
laboratory nonconformance (event) management
-
2:24
prevalence of btk and plcγ2 mutations in cll relapsing under ibrutinib
-
2:23
non-covalent vs covalent btk inhibitors in cll
-
1:04
the current limitations of mouse models of cll: moving towards humanized models
-
1:53
challenges in developing immunotherapies for cll compared to other hematologic malignancies
-
1:21
overview of the role of non-covalent btk inhibitors in the era of covalent btk inhibitors
-
1:33
cellular and non-cellular immunotherapies in cll
-
1:24
sequencing of btk inhibitors in cll
-
2:08
an insight into the current understanding of risk factors for cll
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:00
ibrutinib: use in small cll subgroups only?
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
2:09
targeting mitochondrial metabolism in cml
-
1:49
genomic advancements in non-malignant hematology
-
2:36
novel non-immunological agents currently under investigation for cll